These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9251655)

  • 1. Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir.
    Matsuda J; Gohchi K
    Lancet; 1997 Aug; 350(9074):364. PubMed ID: 9251655
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hepatitis in three AIDS patients treated with indinavir.
    Bräu N; Leaf HL; Wieczorek RL; Margolis DM
    Lancet; 1997 Mar; 349(9056):924-5. PubMed ID: 9093260
    [No Abstract]   [Full Text] [Related]  

  • 3. Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir.
    Benveniste O; Longuet P; Duval X; Le Moing V; Leport C; Vildé JL
    Clin Infect Dis; 1999 May; 28(5):1180-1. PubMed ID: 10452668
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the combination of hepatitis and indinavir potentially dangerous?
    Jeurissen FJ; Schneider MM; Borleffs JC
    AIDS; 1998 Mar; 12(4):441-2. PubMed ID: 9520177
    [No Abstract]   [Full Text] [Related]  

  • 5. Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS.
    Gariano RF; Cooney EL
    Clin Infect Dis; 1997 Mar; 24(3):529. PubMed ID: 9114223
    [No Abstract]   [Full Text] [Related]  

  • 6. Indinavir-associated hepatitis in patients with advanced HIV infection.
    Vergis E; Paterson DL; Singh N
    Int J STD AIDS; 1998 Jan; 9(1):53. PubMed ID: 9518018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progressive multifocal leukoencephalopathy in patients with AIDS. Hepatotoxicity of HAART therapy in patients with coinfection by HBV or HCV].
    Blanco Barrios A; Gutiérrez Vivas A; Zancada Díaz de Entre-Sotos F; Calderón Mariño N
    Rev Clin Esp; 2004 Apr; 204(4):238-40. PubMed ID: 15104941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Managing side effects. Individualized dosage makes indinavir more tolerable].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():84. PubMed ID: 15011605
    [No Abstract]   [Full Text] [Related]  

  • 9. [A plea for an individualized therapy regimen. Which is the optimal dose?].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():26-7. PubMed ID: 12043067
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis.
    Furrer H; Malinverni R
    Am J Med; 1999 Mar; 106(3):371-2. PubMed ID: 10190387
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome.
    Sonderup MW; Wainwright H; Hall P; Hairwadzi H; Spearman CW
    Hepatology; 2015 May; 61(5):1721-9. PubMed ID: 25644940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal acute haemolysis in an AIDS patient treated with indinavir.
    Prazuck T; Semaille C; Roques S
    AIDS; 1998 Mar; 12(5):531-3. PubMed ID: 9543454
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatotoxicity with antiretroviral therapy. The liver is affected as well].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():14-5. PubMed ID: 12043064
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of rash with indinavir in a national patient cohort.
    Gajewski LK; Grimone AJ; Melbourne KM; Vanscoy GJ
    Ann Pharmacother; 1999 Jan; 33(1):17-21. PubMed ID: 9972379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria.
    Perazella MA; Kashgarian M; Cooney E
    Clin Nephrol; 1998 Sep; 50(3):194-6. PubMed ID: 9776425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virodene--support misguided.
    Folb PI; van Gelder A; Swan GE
    S Afr Med J; 1997 Apr; 87(4):466. PubMed ID: 9254793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indinavir urolithiasis in HIV-positive patients. Treatment and prophylaxis].
    Kalaitzis C; Touloupidis S; Patris E; Lehrich K; Kuntz RM
    Urologe A; 2004 Feb; 43(2):168-71. PubMed ID: 14991118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS-related thrombocytopenia. Experience of a medium-term treatment with intravenous IgG in haemophilia B patients.
    Leipnitz G; Köhler M; Pindur G; Wenzel E
    Vox Sang; 1989; 56(1):57-8. PubMed ID: 2916336
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephrolithiasis from indinavir, a new human immunodeficiency virus drug.
    Lerner LB; Cendron M; Rous SN
    J Urol; 1998 Jun; 159(6):2074; discussion 2074-5. PubMed ID: 9598523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.